IL-4 and IL-13 inhibit IL-1 beta and TNF-alpha induced kinin B-1 and B-2 receptors through a STAT6-dependent mechanism
dc.contributor.author | Souza, P. P. C. | |
dc.contributor.author | Brechter, A. B. | |
dc.contributor.author | Reis, R. I. [UNIFESP] | |
dc.contributor.author | Costa, C. A. S. | |
dc.contributor.author | Lundberg, P. | |
dc.contributor.author | Lerner, U. H. | |
dc.contributor.institution | Umea Univ | |
dc.contributor.institution | Univ Estadual Paulista | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Univ Gothenburg | |
dc.date.accessioned | 2016-01-24T14:31:37Z | |
dc.date.available | 2016-01-24T14:31:37Z | |
dc.date.issued | 2013-05-01 | |
dc.description.abstract | Background and Purpose Bone resorption induced by interleukin-1 (IL-1) and tumour necrosis factor (TNF-) is synergistically potentiated by kinins, partially due to enhanced kinin receptor expression. Inflammation-induced bone resorption can be impaired by IL-4 and IL-13. the aim was to investigate if expression of B1 and B2 kinin receptors can be affected by IL-4 and IL-13. Experimental Approach We examined effects in a human osteoblastic cell line (MG-63), primary human gingival fibroblasts and mouse bones by IL-4 and IL-13 on mRNA and protein expression of the B1 and B2 kinin receptors. We also examined the role of STAT6 by RNA interference and using Stat6-/- mice. Key Results IL-4 and IL-13 decreased the mRNA expression of B1 and B2 kinin receptors induced by either IL-1 or TNF- in MG-63 cells, intact mouse calvarial bones or primary human gingival fibroblasts. the burst of intracellular calcium induced by either bradykinin (B2 agonist) or des-Arg10-Lys-bradykinin (B1 agonist) in gingival fibroblasts pretreated with IL-1 was impaired by IL-4. Similarly, the increased binding of B1 and B2 ligands induced by IL-1 was decreased by IL-4. in calvarial bones from Stat6-deficient mice, and in fibroblasts in which STAT6 was knocked down by siRNA, the effect of IL-4 was decreased. Conclusions and Implications These data show, for the first time, that IL-4 and IL-13 decrease kinin receptors in a STAT6-dependent mechanism, which can be one important mechanism by which these cytokines exert their anti-inflammatory effects and impair bone resorption. | en |
dc.description.affiliation | Umea Univ, Dept Mol Periodontol, SE-90187 Umea, Sweden | |
dc.description.affiliation | Univ Estadual Paulista, Dept Physiol & Pathol, Araraquara Sch Dent, Araraquara, Brazil | |
dc.description.affiliation | Universidade Federal de São Paulo, Dept Med, Nephrol Div, São Paulo, Brazil | |
dc.description.affiliation | Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Dept Med, Nephrol Div, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Swedish Research Council for Medicine | |
dc.description.sponsorship | Swedish Rheumatism Association | |
dc.description.sponsorship | County Council of Vasterbotten | |
dc.description.sponsorship | Swedish Dental Society, Combine, Salus Ansvar | |
dc.description.sponsorship | Lundberg Foundation | |
dc.description.sponsorship | ALF/LUA grant from the Sahlgrenska University Hospital, | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorshipID | ALF/LUA grant from the Sahlgrenska University Hospital,: 2008/58958-7 | |
dc.description.sponsorshipID | ALF/LUA grant from the Sahlgrenska University Hospital,: 2008/07221-4 | |
dc.description.sponsorshipID | FAPESP: 2008/58958-7 | |
dc.description.sponsorshipID | FAPESP: 2008/07221-4 | |
dc.description.sponsorshipID | CNPq: 301291/2010 PQ | |
dc.format.extent | 400-412 | |
dc.identifier | http://dx.doi.org/10.1111/bph.12116 | |
dc.identifier.citation | British Journal of Pharmacology. Hoboken: Wiley-Blackwell, v. 169, n. 2, p. 400-412, 2013. | |
dc.identifier.doi | 10.1111/bph.12116 | |
dc.identifier.issn | 0007-1188 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/36240 | |
dc.identifier.wos | WOS:000318234600013 | |
dc.language.iso | eng | |
dc.publisher | Wiley-Blackwell | |
dc.relation.ispartof | British Journal of Pharmacology | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights.license | http://olabout.wiley.com/WileyCDA/Section/id-406071.html | |
dc.subject | interleukin-4 | en |
dc.subject | interleukin-13 | en |
dc.subject | interleukin-1 | en |
dc.subject | tumour necrosis factor- | en |
dc.subject | kinin receptors | en |
dc.subject | STAT6 | en |
dc.title | IL-4 and IL-13 inhibit IL-1 beta and TNF-alpha induced kinin B-1 and B-2 receptors through a STAT6-dependent mechanism | en |
dc.type | info:eu-repo/semantics/article |